日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Chinese clinical trial shows breakthrough in liver cancer survival

By ZHOU WENTING in Shanghai | chinadaily.com.cn | Updated: 2026-03-05 21:29
Share
Share - WeChat
Doctors from Shanghai-based Zhongshan Hospital, affiliated with Fudan University, brief the media on Thursday on the results of a multicenter clinical study showing that an innovative neoadjuvant treatment for intrahepatic cholangiocarcinoma, a common malignant liver tumor, can significantly extend patient survival. [Photo provided to chinadaily.com.cn]

A pioneering Chinese study has found that a new drug cocktail administered before surgery can nearly double the time patients with a deadly form of liver cancer live without the disease returning.

The study, published Thursday in the New England Journal of Medicine, focused on intrahepatic cholangiocarcinoma, or ICC. This cancer forms in the bile ducts inside the liver and is notorious for being "silent," often discovered only after it has reached an advanced stage.

Led by Zhongshan Hospital, affiliated with Fudan University, the trial involved 11 hospitals across China. Experts say the findings offer a new "standard of care" for a disease where the five-year survival rate after surgery is currently only 25 percent to 40 percent.

The researchers tested a neoadjuvant protocol, which is a treatment given as a first step to shrink a tumor before the main surgery. In this trial, 178 patients with a median age of 59 were recruited by February 2025. One group received three cycles of Gemox chemotherapy along with a targeted therapy drug and an immunotherapy drug, which helps the body's own immune system recognize and attack cancer cells. The other group underwent immediate surgery, which is the traditional standard practice.

The results showed that the drug combination significantly delayed the return of the cancer. The median event-free survival — the length of time after treatment that a patient remains free of specific complications or cancer recurrence — was 18 months for those who received the drug cocktail. In contrast, the group that went straight to surgery saw a median of only 8.7 months.

Shi Guoming, one of the lead researchers, noted that the tumors in the drug-treatment group significantly shrank, with an objective response rate of 55 percent. This term refers to the percentage of patients whose tumors partially or completely disappeared during the treatment phase.

China is disproportionately affected by this disease, seeing over 50,000 new cases annually, which accounts for more than half of the global total. The study, which began in 2021, also showed a promising trend in overall survival. The 24-month survival rate for the drug-protocol group was 79 percent, compared to 61 percent for the surgery-only group.

Zhou Jian, president of Zhongshan Hospital, said that as the study progresses, it may further demonstrate long-term benefits for patients. The team presented preliminary results at the annual meeting of the European Society for Medical Oncology in Germany in October 2025, where it garnered international attention. Shi expressed hope that the findings will be further validated through international studies so the Chinese protocol can eventually be used as a global cure.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 国产99精品 | 国产成人综合欧美精品久久 | 国产一级片免费观看 | 伊人网在线免费 | 亚洲狼人综合 | 欧美日韩一区三区 | 欧美久操 | 成人一二区| 久久久久久久久福利 | 亚洲天堂免费在线 | 久久黄色免费网站 | 中文字幕日韩视频 | 日韩欧美福利视频 | 日本www免费| 日韩中文视频 | 日韩在线免费av | 国产区精品视频 | 自拍天堂 | 日韩欧美视频在线播放 | 成人h网站 | 日韩成人高清视频 | 国产精品麻豆一区二区 | 免费啪视频在线观看 | 日韩免费观看视频 | 超碰在线小说 | 在线观看天堂av | 黄色免费网站视频 | 黄色免费看片 | 国产黄色片免费 | 国产成人在线视频播放 | 久久精品久久精品 | 久久久久久久久久久91 | 婷婷色吧 | 成人高清 | 成年人免费av | 亚洲国产一区二区三区在线观看 | 国产在线久 | 一区二区欧美日韩 | 欧美有码视频 | 我我色综合 | 亚洲色图88|